Abstract:
The low energy electron emitter 161Tb was produced n.c.a. in quantities sufficient for therapeutic applications and successfully used for labeling of peptides and antibodies. Furthermore, these compounds have been compared to n.c.a. 177Lu labeled mAbs via cell experiments, a radionuclide that is already used in clinical nuclear oncology.